Cross-contamination of CRISPR guides and other unrelated nucleotide sequences among commercial oligonucleotides

• Published in: Nucleic acids research Vol. 52; no. 6; pp. 3137 - 3145
• Main Authors: Arakawa, Hiroshi, Miura, Hiromi, Quadros, Rolen M, Ohtsuka, Masato, Gurumurthy, Channabasavaiah B
• Format: Journal Article
• Language: English
• Published: England 12-04-2024
• Subjects: Base Sequence; Clustered Regularly Interspaced Short Palindromic Repeats - genetics; Drug Contamination; Genetic Techniques; Indicators and Reagents - analysis; Indicators and Reagents - standards; Industry - standards; Oligonucleotides - chemistry; Oligonucleotides - standards
• ISSN: 0305-1048; 1362-4962
• DOI: 10.1093/nar/gkae068

Custom oligonucleotides (oligos) are widely used reagents in biomedical research. Some common applications of oligos include polymerase chain reaction (PCR), sequencing, hybridization, microarray, and library construction. The reliability of oligos in such applications depends on their purity and specificity. Here, we report that commercially available oligos are frequently contaminated with nonspecific sequences (i.e. other unrelated oligonucleotides). Most of the oligos that we designed to amplify clustered regularly interspersed palindromic repeats (CRISPR) guide sequences contained nonspecific CRISPR guides. These contaminants were detected in research-grade oligos procured from eight commercial oligo-suppliers located in three different geographic regions of the world. Deep sequencing of some of the oligos revealed a variety of contaminants. Given the wide range of applications of oligos, the impact of oligo cross-contamination varies greatly depending on the field and the experimental method. Incorporating appropriate control experiments in research design can help ensure that the quality of oligo reagents meets the intended purpose. This can also minimize risk depending on the purposes for which the oligos are used.